Locations:

Waldenström Macroglobulinemia

Waldenström macroglobulinemia (WM) — also known as lymphoplasmacytic lymphoma — is a rare, slow-growing cancer that affects your blood cells. WM happens when genetic mutations change your B cells. Healthcare providers can’t cure this condition, but they do have treatments that can manage symptoms.

What Is Waldenström Macroglobulinemia?

Waldenström macroglobulinemia (pronounced “wal-den-strom” “mac-ro-glob-u-lin-e-mia”) is a slow-growing blood cancer. It’s a type of non-Hodgkin lymphoma that also goes by another name: lymphoplasmacytic lymphoma. A rare cancer, Waldenström macroglobulinemia (WM) only affects about 3 to 4 out of every 1 million people in the U.S.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

WM happens when B cells (immune cells) in your bone marrow (where blood cells get made) change into cancer cells. The cancer cells copy themselves and can crowd out your normal blood cells. This can lead to low numbers of red blood cells (anemia), white blood cells (neutropenia) and platelets (thrombocytopenia).

The cancer cells also release an abnormal protein called immunoglobulin M (IgM). Too much IgM can thicken your blood, turning it into a syrup-like liquid. This is called hyperviscosity syndrome. The thickened blood doesn’t flow easily through your body’s tiny blood vessels and can cause serious symptoms.

There’s no cure for Waldenström macroglobulinemia. But there are treatments that ease and sometimes eliminate symptoms. As WM tends to progress slowly, it’s possible that you’ll live many years with this condition.

Symptoms and Causes

Symptoms of Waldenström macroglobulinemia

One in 4 people diagnosed with WM don’t have symptoms. They learn they have this condition while visiting their healthcare provider for other reasons. When WM does cause symptoms, they come on slowly. Symptoms include:

Advertisement

Waldenström macroglobulinemia causes

Genetic mutations cause Waldenström macroglobulinemia. More than 90% of people (9 out of 10) with WM have a mutation involving the MYD88 gene. And about 40% (4 out of 10) have changes to their CXCR4 gene. Both mutations help the abnormal cells in Waldenström macroglobulinemia multiply.

These changes aren’t inherited (hereditary). This means you can’t pass this on to your children, and you didn’t get it from your parents. Instead, they develop during your lifetime. But researchers don’t know what triggers the mutations in the first place.

Risk factors

Factors that may increase your chance of developing Waldenström macroglobulinemia include your:

  • Age. Most people diagnosed are 65 and older.
  • Race. WM is most common in people who are white.
  • Sex. Males are more likely to have WM.
  • Medical history. Having hepatitis C, AIDS, Sjögren's Syndrome or MGUS may increase your risk. MGUS is a precursor for WM. But just because you have MGUS doesn’t mean that you’ll develop WM.
  • Family’s medical history. Having biological family members who have WM or other kinds of lymphoma may increase your risk.

Complications of this condition

In severe cases, WM can cause complications, including:

  • Amyloidosis. This condition happens when faulty proteins build up in organs like your heart, lungs and kidneys.
  • Cryoglobulinemia. This condition happens when certain blood proteins that react to cold conditions gather in clumps in your hands and feet. This can cause pain and turn your hands and feet blue or white (cyanosis).

Diagnosis and Tests

How do doctors diagnose this condition?

Your healthcare provider may use several tests to diagnose Waldenström macroglobulinemia. They look for cancer cells and IgM proteins. Tests include:

Management and Treatment

How is Waldenström macroglobulinemia treated?

As there isn’t a cure for this condition, the best treatment is one that relieves symptoms with the least amount of side effects. Your healthcare provider will work with you to customize treatment. Options for WM include:

  • Watchful waiting. Your provider may not start treatment if you don’t have symptoms. Some people with WM don’t need treatment for years.
  • Plasmapheresis (plasma exchange). Providers use a machine to filter abnormal IgM from your plasma, the liquid part of your blood. They return the plasma to your bloodstream. Providers use this treatment to ease symptoms caused by thickening blood.
  • Immunotherapy. This treatment uses your body’s immune system to destroy or slow the growth of WM cells. Providers commonly prescribe rituximab (Rituxan®) alone or with chemotherapy.
  • Chemotherapy. Your providers may prescribe cancer-killing medications alone or in combination with immunotherapy.
  • Corticosteroids. You may take a steroid, like dexamethasone, along with immunotherapy and chemo. This treatment fights cancer and reduces the side effects of treatment.
  • Targeted therapy. This treatment blocks proteins that cancer cells use to make more copies. Ibrutinib (Imbruvica®) and zanubrutinib (Brukinsa®) are both targeted therapies approved by the U.S. Food and Drug Administration (FDA) to treat WM.
  • Stem cell transplant. Providers replace bone marrow affected by abnormal cells with healthy bone marrow. This is uncommon and used only in select people.

Advertisement

When should I seek care?

Contact your healthcare provider if you’ve been diagnosed with WM and have a symptom that’s new or bothering you. If you learn you have this condition, it’s important to ask questions so you know what to expect. Here are a few questions you may want to ask your provider:

  • How serious is WM, and how will it affect my life?
  • What should I expect in the short term and long term?
  • Do I need treatment right away?
  • What type of treatment do you recommend?
  • What treatment side effects should I expect?

Outlook / Prognosis

What can I expect if I have this condition?

Everyone’s situation is different, particularly with a condition that progresses slowly like Waldenström macroglobulinemia. Research shows that 66% of people (more than 2 out of 3) are alive 10 years after they’re diagnosed. But life expectancy varies by age. Many people diagnosed over age 65 (the most commonly diagnosed age group) die from causes unrelated to WM.

Your prognosis (likely outcome) depends on lots of factors, including your:

  • Age
  • Blood test results
  • Mutation type (not having an MYD88 mutation sometimes suggests a worse outcome)

If you have questions about your situation, talk to your healthcare provider. They know you and the circumstances that may affect your health.

Is there anything I can do to feel better?

Living with a lymphoma like Waldenström macroglobulinemia often requires major life adjustments. It’s important to take advantage of every resource you can. Talk with your healthcare provider about what foods to eat and what activities will promote self-care.

Advertisement

Reach out to others with rare conditions to combat possible feelings of isolation. You’re not alone in your diagnosis — even if it feels like it at first. Ask your provider to connect you with support groups.

A note from Cleveland Clinic

Researchers haven’t discovered a cure for Waldenström macroglobulinemia (WM) yet. But they’ve found several treatments that can make living with it more manageable. Many people live with this condition for years without symptoms. Treatments are helping people with WM live longer than ever without sacrificing their quality of life. If you receive this diagnosis, ask your healthcare provider about your short-term and long-term outlook. They can help you decide on the best care plan.

Advertisement

Care at Cleveland Clinic

We offer comprehensive Waldenstrom macroglobulinemia care. Our experts use the latest tests and treatments to offer the most personalized care.

Medically Reviewed

Last reviewed on 04/15/2025.

Learn more about the Health Library and our editorial process.

Ad
Cancer Answer Line 866.223.8100